SEC Comment Letter for CV Sciences, Inc. (CVSI) (CIK 0001510964) (CVSI) — Apr 24, 2020
CV Sciences, Inc. (CVSI) (CIK 0001510964)
Date: April 24, 2020 · CIK: 0001510964 · Accession: 0000000000-20-003538
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-237772
Letter
April 24, 2020 Joseph D. Dowling Chief Executive Officer CV Sciences, Inc. 10070 Barnes Canyon Road San Diego, CA 92121 Re:CV Sciences, Inc. Registration Statement on Form S-3 Filed April 21, 2020 File No. 333-237772 Dear Mr. Dowling: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jeffrey Gabor at 202-551-2544 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Craig M. Garner, Esq.
Show Raw Text
April 24, 2020
Joseph D. Dowling
Chief Executive Officer
CV Sciences, Inc.
10070 Barnes Canyon Road
San Diego, CA 92121
Re:CV Sciences, Inc.
Registration Statement on Form S-3
Filed April 21, 2020
File No. 333-237772
Dear Mr. Dowling:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jeffrey Gabor at 202-551-2544 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Craig M. Garner, Esq.